Cover of Evidence reviews for investigations – diagnosis

Evidence reviews for investigations – diagnosis

Spinal metastases and metastatic spinal cord compression

Evidence review F

NICE Guideline, No. 234

London: National Institute for Health and Care Excellence (NICE); .
ISBN-13: 978-1-4731-5316-5
Copyright © NICE 2023.

Investigations - diagnosis

Review question

How effective are radiological imaging techniques in the diagnosis of spinal metastases, direct malignant infiltration of the spine or associated spinal cord compression?

Introduction

The diagnosis of metastatic spinal cord compression or spinal metastases typically requires radiological imaging. Clinical signs may be the same for malignant and benign spinal disease in people with known primary cancer. Some people without known primary cancer present with spinal cord compression as their first symptom. MRI has been the method of choice for investigating malignant spinal disease and cord compression, due to its ability to identify metastatic disease within bone, visualise the soft tissue component of lesions and show the degree of any cord compression. Computed tomography (CT) and fluorodeoxyglucose-positron emission tomography-computed tomography (FDG-PET-CT) also potentially provide additional information. This review aimed to summarise the effectiveness of different radiological imaging techniques in the diagnosis of spinal metastases, direct malignant infiltration of the spine or associated spinal cord compression.

Summary of the protocol

See Table 1 for a summary of the Population, Index test, Reference standard (or Comparator), Target condition and Outcome (PIRTO) characteristics of this review.

Table Icon

Table 1

Summary of the protocol (PIRTO table).

For further details see the review protocol in appendix A.

Methods and process

This evidence review was developed using the methods and process described in Developing NICE guidelines: the manual. Methods specific to this review question are described in the review protocol in appendix A and the methods document (supplementary document 1).

Declarations of interest were recorded according to NICE’s conflicts of interest policy.

Diagnostic evidence

Included studies

Twenty studies were included in this evidence review, 1 randomised trial (Dearnaley 2022), 1 observational study (Allan 2009), 3 systematic reviews (Kim 2020, Li 2019, Suh 2018) and 15 diagnostic accuracy studies (Bacher 2021, Husband 2001, Kato 2015, Kim 2000, Laufer 2009, Maeder 2018, Perry 2018, Phadke 2001, Razek 2019, Schmeel 2018, Schmeel 2021, Shi 2017, Spinnato 2018, Taheri 2017, Zafar 2020).

Test and treat studies

One test-and-treat RCT (Dearnaley 2022) compared screening MRI with no screening MRI in men at high risk of malignant spinal cord compression.

One study (Allan 2009) compared a rapid MRI referral hotline for suspected malignant spinal cord compression with usual care.

Diagnostic test accuracy studies

One systematic review (Suh 2018) and 5 additional studies (Maeder 2018, Perry 2018, Schmeel 2021, Shi 2017, Taheri 2017) evaluated chemical shift MRI for the differential diagnosis of malignant and non-malignant bone marrow lesions.

Two systematic reviews (Li 2019, Suh 2018) and 2 additional studies (Bacher 2021, Schmeel 2018) evaluated chemical shift MRI for the differential diagnosis of malignant and non-malignant vertebral compression fractures.

One systematic review (Li 2019) and 3 additional studies (Kato 2015, Razek 2019, Zafar 2020) evaluated conventional MRI sequences, contrast enhanced MRI and diffusion weighted imaging for the differential diagnosis of malignant and non-malignant vertebral compression fractures.

One systematic review (Kim 2020) evaluated FDG-PET-CT or FDG-PET for the differential diagnosis of malignant and non-malignant vertebral compression fractures.

One study (Husband 2001) evaluated plain radiographs and neurology for the diagnosis of malignant spinal cord compression and for the impact of MRI on treatment planning.

One study (Kim 2000) reported the diagnostic accuracy of T1-weighted sagittal images alone for the for the diagnosis of malignant spinal cord compression.

Three studies (Laufer 2009, Phadke 2001, Spinnato 2018) reported the diagnostic yield of CT-guided biopsy of suspected malignant spinal lesions.

The included studies are summarised in Table 2.

See the literature search strategy in appendix B and study selection flow chart in appendix C.

Excluded studies

Studies not included in this review are listed, and reasons for their exclusion are provided in appendix K.

Summary of included studies

Summaries of the studies that were included in this review are presented in Table 2.

Table Icon

Table 2

Summary of included studies.

See the full evidence tables in appendix D, the forest plots in appendix E and the study data in appendix L.

Summary of the evidence

Screening MRI verses no screening MRI

Evidence from a randomised trial indicated that screening using spinal MRI for people at high risk of metastatic spinal cord compression made no important difference to overall survival. There was also no evidence of important difference in neurological and functional status, pain or quality of life. The evidence quality ranged from low to high.

MSCC hotline verses usual care

Evidence from an observational study showed a benefit of a telephone hotline compared to usual care because it enabled rapid referral and diagnosis of patients with suspected MSCC. Median time from referral to diagnosis was 2 weeks shorter in the telephone hotline group compared to usual care. Patients referred via the hotline were also more likely to be ambulant at the time of diagnosis. The evidence quality ranged from very low to low.

Chemical shift MRI for the differential diagnosis of malignant and non-malignant vertebral bone marrow lesions

Chemical shift MRI had acceptable (>80%) sensitivity and specificity in the differential diagnosis of malignant and non-malignant vertebral bone marrow lesions (BML). Likelihood ratios indicated that chemical shift MRI is a useful test in this context (positive likelihood ratio [LR+] > 5 and negative likelihood ratio [LR−] < 0.2). The evidence quality for this was moderate to high.

FDG-PET for the differential diagnosis of malignant and non-malignant vertebral compression fractures

FDG-PET or FDG-PET-CT had acceptable (>80%) sensitivity for the differential diagnosis of malignant and non-malignant VCF, but somewhat lower specificity suggesting false positives would be an issue with this imaging modality. Likelihood ratios indicated that FDG-PET or FDG-PET-CT was potentially a useful test (LR+ between 2 and 5, LR− <0.2) again indicating some uncertainty in positive test results. The evidence quality for this was low.

Chemical shift MRI for the differential diagnosis of malignant and non-malignant vertebral compression fractures

Chemical shift MRI had acceptable (>80%) sensitivity and specificity for differential diagnosis of malignant and non-malignant vertebral compression fractures (VCF). Likelihood ratios indicated that chemical shift MRI is a useful test in this context (LR+ > 5, LR− < 0.2). The evidence quality for this was moderate to high.

Conventional MRI sequences(with or without DWI) for the differential diagnosis of malignant and non-malignant vertebral compression fractures

Conventional MRI sequences with or without diffusion weighted imaging or contrast enhancement had acceptable sensitivity and specificity for differential diagnosis of VCF. Likelihood ratios indicated that conventional MRI sequences with diffusion weighted imaging is a useful test in this context (LR+ > 5, LR− < 0.2). The evidence quality for this was moderate. Likelihood ratios indicated that conventional MRI sequences are a useful test in this context (LR+ > 5, LR− < 0.2). The evidence quality for this was very low to moderate.

Tests for diagnosis of metastatic spinal cord compression

Evidence for imaging diagnosis of spinal cord compression was more limited. One study indicated that T1-weighted sagittal MRI images alone had relatively low sensitivity but high specificity for spinal cord compression. Likelihood ratios indicated this was potentially a useful test (LR+ > 5, LR− between 0.2 and 0.5). Another observational study found that plain radiographs plus neurological examination had very low sensitivity but high specificity for spinal cord compression. The likelihood ratios indicated plain radiographs plus neurological examination was unlikely to be a useful test for metastatic spinal cord compression (LR+ > 5, LR− > 0.5). The evidence quality for this was low.

Very low quality evidence suggested that CT-guided biopsies of suspected metastatic spinal lesions do not always provide sufficient material for diagnosis. There was uncertainty, however, about how often this occurs with reported diagnostic yields ranging from 81% to 99% in the included studies.

See appendix F for GRADE and modified GRADE tables.

Economic evidence

Included studies

A systematic review of the economic literature was conducted but no economic studies were identified which were applicable to this review question.

A single economic search was undertaken for all topics included in the scope of this guideline. See supplement 2 for details.

Excluded studies

Economic studies not included in this review are listed, and reasons for their exclusion are provided in supplement 2.

No economic modelling was undertaken for this review because the committee agreed that other topics were higher priorities for economic evaluation.

The committee's discussion and interpretation of the evidence

The outcomes that matter most

Critical outcomes were overall survival, disease related morbidity, neurological/functional status and quality of life. This was because prompt and accurate diagnosis should lead to appropriate treatment, avoiding the morbidity caused by spinal cord compression and potentially prolonging life. For this reason, diagnostic accuracy was also a critical outcome.

Pain was an important outcome because it is a common symptom of metastatic spinal disease with negative impact on quality of life. Time to treatment was an important outcome because diagnostic uncertainty can delay treatment. Also, referral for specialist tests or dealing with equivocal test results can cause treatment delays. False positive test results can have important consequences in this group, leading to unnecessary treatment or biopsy. Morbidity caused by biopsy was included as an important outcome for this reason. Finally test failure was included as an important outcome, because sometimes diagnostic tests do not produce a clear positive or negative result, leading to uncertainty, repeated tests and diagnostic delays.

The quality of the evidence

The quality of the evidence rated using GRADE ranged from low to high. The main issues that lowered the quality of the outcomes were risk of bias and imprecision.

No evidence was identified relating to CT scans or for the outcomes of disease-related morbidity, pain, consequences of false positives and morbidity due to biopsy.

Benefits and harms
Radiologist involvement

Based on their knowledge and experience the committee noted that carrying out radiological imagining of the spine and interpreting the results is complex (for example, selecting the correct sequencing and, if necessary, supplementary axial imaging) and that the impact of errors may have very serious consequences. In their experience there is also variation in how urgently results are reported, which can affect starting timely treatment. The committee agreed that imaging should be overseen by a radiologist. It was discussed that having a radiologist present at all MRI imaging appointments for MSCC would be difficult because of the urgency in which they would need to be conducted. They noted that it is now possible that scans can be overseen virtually which means that a radiologist would not necessarily need to be there in person but could oversee it remotely. Having a radiologist there also means that they can interpret and report the findings promptly.

The committee discussed the evidence showing an important benefit of a telephone hotline compared to usual care. They noted that it enabled rapid referral and diagnosis of patients with suspected MSCC. They agreed that any pathway to urgent MRI is useful and there are service configurations that work in some areas but not others. However, they decided not to recommend a hotline for MRI because they did not want to be prescriptive about how services organise their MRI lists to provide urgent access. They acknowledged that this is addressed in another part of the guideline that is focused on service configuration to support urgent MRI diagnosis of MSCC (see evidence review A).

MRI assessment

Based on the evidence and their experience the committee agreed that conventional MRI sequences (including T1-weighted imaging, T2-weighted imaging and short TI inversion recovery (STIR) sequences) have acceptable sensitivity and specificity (considerably higher than the committee’s decision threshold of 80%) for identifying metastatic disease within bone when the correct sequences are used, and they listed the appropriate sequences in their recommendation. Sagittal T1 and/or STIR sequences of the whole spine would be used identify spinal metastases. Whereas sagittal T2 weighted sequences (with supplementary axial imaging) can also show any soft tissue component of the mass and the degree of spinal cord compression.

The committee discussed the evidence on adding contrast-enhanced MRI, diffusion weighted imaging or chemical shift MRI to conventional sequences which may have a role in differentiating normal versus malignant bone marrow or osteoporotic versus malignant compression fractures. They were not convinced the evidence supported routinely adding these additional sequences to conventional MRI because the main role of MRI in this context is to identify the presence or absence of metastases and involvement of the spinal cord, rather than differentiate benign verses malignant lesions or fractures, however they understood that these additional sequences may be useful in selected cases and that local protocols or guidelines would be typically in place for their use.

They recommended not to perform routine MRI in people without symptoms or signs of cord compression in order to screen for MSCC, because evidence from a randomised trial did not demonstrate any benefit of surveillance MRIs in people who are asymptomatic but are at high risk of MSCC.

Other imaging techniques for diagnosis and management

Although there was no evidence about the use of CT in diagnosis of metastatic spinal disease the committee acknowledged that MRI might be contraindicated in some people (for instance anyone with metal implants). They considered CT was an appropriate alternative (although less sensitive than modern MRI) for imaging the spine in these cases and widely used for cancer staging. They acknowledged, based on experience that in rare cases there may be an indication for CT myelography, but this would need to be done in a specialist centre because it is an invasive procedure which is associated with some risks.

The committee discussed that many patients presenting with symptoms of spinal metastases or cord compression may have already had plain X-rays as initial investigations, but they agreed based on their experience that plain X-rays were not as sensitive for detecting metastatic bone disease as MRI and recommended they should not be used to diagnose or rule out spinal metastases, direct malignant infiltration (DMI) of the spine or MSCC. There was also evidence that X-rays and neurological examination would detect less than half of the cases of spinal cord compression which can accompany spinal metastases.

The committee noted the evidence showing that CT-guided biopsies of suspected metastatic spinal lesions do not always provide sufficient material for diagnosis. However, they decided that due to the very low quality there was too much uncertainty about this evidence to base a recommendation on.

Cost effectiveness and resource use

No economic evidence was identified for this topic from the systematic search of previously published evidence. The committee considered cost effectiveness based on their own experience and knowledge.

Recommendations for this topic will lead to cost savings with no or limited impact on outcomes for people receiving these healthcare services. Whilst imaging being overseen by a radiologist would take up their time and associated costs the consequences of missing important details would be serious which would accrue larger costs in the long term. Recommendations against routine MRI in people without symptoms or signs of MSCC should reduce the number of MRIs undertaken although only a handful of centres are currently performing MRI in these circumstances. RCT evidence suggests this will have no impact upon outcomes or quality of life for patients.

Recommendations against x-ray, although a less expensive imaging technique should reduce costs as the diagnostic utility of them is very limited and MRI diagnostic imaging would always have to be carried out to get sufficiently detailed information to locate the tumour and plan treatment.

Recommendations supported by this evidence review

This evidence review supports recommendations 1.5.1 and 1.5.5 to 1.5.9 in the NICE guideline.

References – included studies

    Diagnostic

    • Allan 2009

      Allan L, Baker L, Dewar J, et al Suspected malignant cord compression – Improving time to diagnosis via a hotline: A prospective audit. British Journal of Cancer, 100, 1867–1872, 2009 [PMC free article: PMC2714247] [PubMed: 19471276]

    • Bacher 2021

      Bacher S, Hajdu S, Maeder Y, et al Differentiation between benign and malignant vertebral compression fractures using qualitative and quantitative analysis of a single fast spin echo T2-weighted Dixon sequence. European Radiology, 31, 9418–942, 2021 [PMC free article: PMC8589814] [PubMed: 34041569]

    • Dearnaley 2022

      Dearnaley D, Hinder V, Hijab A, et al Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial. Lancet: Oncology, 23, 501–513, 2022 [PMC free article: PMC8960282] [PubMed: 35279270]

    • Husband 2001

      Husband D, Grant K, Romaniuk C. MRI in the diagnosis and treatment of suspected malignant spinal cord compression. British Journal of Radiology 74, 15–23, 2001 [PubMed: 11227772]

    • Kato 2015

      Kato S, Hozumi T, Yamakawa K, et al META: an MRI-based scoring system differentiating metastatic from osteoporotic vertebral fractures. Spine Journal, 15, 1563–70, 2015 [PubMed: 25777741]

    • Kim 2000

      Kim J, Learch T, Colletti P, et al Diagnosis of vertebral metastasis, epidural metastasis, and malignant spinal cord compression: are T(1)-weighted sagittal images sufficient? Magnetic Resonance Imaging 18, 819–24, 2000 [PubMed: 11027875]

    • Kim 2020

      Kim S, Lee J. (2020) Diagnostic performance of F-18 FDG PET or PET/CT for differentiation of benign from malignant vertebral compression fractures; A meta-analysis. World Neurosurgery, 137: e626–e633, 2020 [PubMed: 32105873]

    • Laufer 2009

      Laufer I, Lis E, Pisinski L, et al The accuracy of [(18) F] fluorodeoxyglucose positron emission tomography as confirmed by biopsy in the diagnosis of spine metastases in a cancer population. Neurosurgery, 64, 107–4, 2009 [PubMed: 19145159]

    • Li 2019

      Li K, Huang L, Lang Z, et al Reliability and Validity of Different MRI Sequences in Improving the Accuracy of Differential Diagnosis of Benign and Malignant Vertebral Fractures: A Meta-Analysis. American Journal of Roentgenology, 213, 427–436, 2019 [PubMed: 31039028]

    • Maeder 2018

      Maeder Y, Dunet V, Richard R, et al Bone Marrow Metastases: T2-weighted Dixon Spin-Echo Fat Images Can Replace T1-weighted Spin-Echo Images. Radiology, 286, 948–959, 2018 [PubMed: 29095674]

    • Perry 2018

      Perry M, and Sebro R. Accuracy of Opposed-phase Magnetic Resonance Imaging for the Evaluation of Treated and Untreated Spinal Metastases. Academic Radiology, 25, 877–882, 2018 [PubMed: 29398437]

    • Phadke 2001

      Phadke D, Lucas D, Madan S. Fine-needle aspiration biopsy of vertebral and intervertebral disc lesions: specimen adequacy, diagnostic utility, and pitfalls. Archives of Pathology and Laboratory Medicine, 125, 1463–8, 2001 [PubMed: 11698003]

    • Razek 2009

      Razek A, Sherif F. Diagnostic accuracy of diffusion tensor imaging in differentiating malignant from benign compressed vertebrae. Neuroradiology, 61, 1291–1296, 2019 [PubMed: 31492969]

    • Schmeel 2018

      Schmeel F, Luetkens J, Feist A, et al Quantitative evaluation of T2* relaxation times for the differentiation of acute benign and malignant vertebral body fractures. European Journal of Radiology, 108, 59–65, 2018 [PubMed: 30396672]

    • Schmeel 2021

      Schmeel F, Enkirch S, Luetkens J, et al Diagnostic Accuracy of Quantitative Imaging Biomarkers in the Differentiation of Benign and Malignant Vertebral Lesions: Combination of Diffusion-Weighted and Proton Density Fat Fraction Spine MRI. Clinical Neuroradiology, 31, 1059–1070, 2021 [PMC free article: PMC8648653] [PubMed: 33787957]

    • Shi 2017

      Shi Y, Li X, Zhang X, et al Differential diagnosis of hemangiomas from spinal osteolytic metastases using 3.0 T MRI: comparison of T1-weighted imaging, chemical-shift imaging, diffusion-weighted and contrast-enhanced imaging. Oncotarget, 8, 71095–71104, 2017 [PMC free article: PMC5642620] [PubMed: 29050345]

    • Spinnato 2018

      Spinnato P, Bazzocchi A, Facchini G, et al Vertebral Fractures of Unknown Origin: Role of Computed Tomography-Guided Biopsy. International Journal of Spine Surgery, 12, 673–679, 2018 [PMC free article: PMC6314342] [PubMed: 30619670]

    • Suh 2018

      Suh C, Yun S, Jin W, et al Diagnostic Performance of In-Phase and Opposed-Phase Chemical-Shift Imaging for Differentiating Benign and Malignant Vertebral Marrow Lesions: A Meta-Analysis. American Journal of Roentgenology 211, W1–W10, 2018 [PubMed: 30160981]

    • Taheri 2017

      Taheri M, Mirzaei H, Shahhamzei S, et al Comparison of chemical shift MR imaging findings between vertebral benign and metastatic lesions. International Journal of Cancer Management 10, e8661, 2017

    • Zafar 2020

      Zafar U, Malik A, Shahzad I, et al Diagnostic accuracy of qualitative diffusion weighted MRI of spine in differentiating between benign and malignant vertebral fractures taking histopathology as gold standard. Pakistan Journal of Medical and Health Sciences 14, 390–392, 2020

Appendices

Appendix G. Economic evidence study selection

Study selection for: How effective are radiological imaging techniques in the diagnosis of spinal metastases, direct malignant infiltration of the spine or associated spinal cord compression?

No economic evidence was identified which was applicable to this review question.

Appendix H. Economic evidence tables

Economic evidence tables for review question: How effective are radiological imaging techniques in the diagnosis of spinal metastases, direct malignant infiltration of the spine or associated spinal cord compression?

No evidence was identified which was applicable to this review question.

Appendix I. Economic model

Economic model for review question: How effective are radiological imaging techniques in the diagnosis of spinal metastases, direct malignant infiltration of the spine or associated spinal cord compression?

No economic analysis was conducted for this review question.

Appendix J. Excluded studies

Excluded studies for review question: How effective are radiological imaging techniques in the diagnosis of spinal metastases, direct malignant infiltration of the spine or associated spinal cord compression?

Excluded diagnostic studies
Table Icon

Table 10

Excluded studies and reasons for their exclusion.

Excluded economic studies

No economic evidence was identified for this review. See supplement 2 for further information.

Appendix K. Research recommendations – full details

Research recommendations for review question: How effective are radiological imaging techniques in the diagnosis of spinal metastases, direct malignant infiltration of the spine or associated spinal cord compression?

No research recommendations were made for this review question.